Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adultsHATHERILL, Mark; GELDENHUYS, Hendrik; PIENAAR, Bernadette et al.Vaccine. 2014, Vol 32, Num 31, pp 3982-3988, issn 0264-410X, 7 p.Article

DOSAGE DE L'ISONIAZIDE, DU N-ACETYLISONIAZIDE ET DE L'ACIDE ISONICOTINIQUE PAR POLAROGRAPHIE A TENSION SINUSOIDALE SURIMPOSEEVALLON JJ; BADINAND A; BICHON C et al.1975; ANAL. CHIM. ACTA; PAYS-BAS; DA. 1975; VOL. 78; NO 1; PP. 93-98; ABS. ANGL.; BIBL. 9 REF.Article

SPECTROPHOTOMETRIC DETERMINATION OF ISONIAZID IN PRESENCE OF ITS HYDRAZONES.DEVANI MB; SHISHOO CJ; PATEL MA et al.1978; J. PHARM. SOC.; USA; DA. 1978; VOL. 67; NO 5; PP. 661-663; BIBL. 17 REF.Article

Mechanisms of action of isoniazidTIMMINS, Graham S; DERETIC, Vojo.Molecular microbiology (Print). 2006, Vol 62, Num 5, pp 1220-1227, issn 0950-382X, 8 p.Article

Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazoneMARIAPPAN, T. T; JINDAL, K. C; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 4, pp 905-908, issn 0731-7085, 4 p.Article

Study of the interaction between rifapentine and isoniazid under acid conditionsPRASAD, Bhagwat; BHUTANI, Hemant; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1438-1441, issn 0731-7085, 4 p.Article

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?KINZIG-SCHIPPERS, Martina; TOMALIK-SCHARTE, Dorota; JETTER, Alexander et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 5, pp 1733-1738, issn 0066-4804, 6 p.Article

Pleuro-péricardite induite par l'isoniazide = Isoniazid-induced pleuro-pericarditisJOUNEAU, S; VOLATRON, A.-C; BRINCHAULT, G et al.Revue de pneumologie clinique (Paris). 2003, Vol 59, Num 6, pp 357-359, issn 0761-8417, 3 p.Article

In vitro studies on the release of isoniazid incorporated in poly(ε-Caprolactone)DURAN, N; DE OLIVEIRA, A. F; DE AZEVEDO, M. M. M et al.Journal of chemotherapy. 2006, Vol 18, Num 5, pp 473-479, issn 1120-009X, 7 p.Article

Amperometric determination of isoniazid in a flowing stream at the glassy carbon electrodeSHAH, M. H; STEWART, J. T.Analytical letters. 1983, Vol 16, Num 12, pp 913-923, issn 0003-2719Article

Flow injection chemiluminescence determination of isoniazid with electrogenerated hypochloriteJIACHU HUANG; CHENGXIAO ZHANG; ZHUJUN ZHANG et al.Fresenius' journal of analytical chemistry. 1999, Vol 363, Num 1, pp 126-128, issn 0937-0633Article

ETUDE DE L'ACTIVITE MUTAGENE DES PREPARATIONS ANTITUBERCULEUSES: HYDRAZIDE DE L'ACIDE ISONICOTINIQUE ET SES DERIVESSHAPIRO AA; MEKSIN VA; ABILEV SK et al.1978; CITOL. I GENET., U.S.S.R.; SUN; DA. 1978; VOL. 12; NO 4; PP. 343-348; ABS. ENG; BIBL. 22 REF.Article

RECHERCHE SUR L'ULTRASTRUCTURE DE CERTAINES SOUCHES DE MYCOBACTERIES DE LA TUBERCULOSE AYANT UNE SENSIBILITE DIFFERENTE A L'ISONIAZIDE ET A LA STREPTOMYCINE, ISOLEES DE MALADESRADANOV R; SPASSOVA N; KALFIN E et al.1972; ANN. SCLAVO; ITAL.; DA. 1972; VOL. 14; NO 1; PP. 103-112; ABS. ITAL. ANGL.; BIBL. 11 REF.Serial Issue

Additive effects of isoniazid preventive therapy and HAARTGOLUB, Jonathan E; CHAISSON, Richard E; MARIONA, Neil A et al.AIDS (London). 2009, Vol 23, Num 11, pp 1446-1447, issn 0269-9370, 2 p.Article

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis InfectionSTERLING, Timothy R; VILLARINO, M. Elsa; WEIS, Stephen E et al.The New England journal of medicine. 2011, Vol 365, Num 23, pp 2155-2166, issn 0028-4793, 12 p.Article

An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutionsBHUTANI, Hemant; MARIAPPAN, T. T; SINGH, Saranjit et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 6, pp 667-672, issn 0363-9045, 6 p.Article

Travail original connaissances actuelles sur le mécanisme d'action de l'isoniazide. Apport d'un modèle chimique d'activation = Action mechanism of antitubercular isoniazid and role of a nonenzymatic activation systemBERNADOU, J; NGUYEN, M; MEUNIER, B et al.Annales pharmaceutiques françaises. 2001, Vol 59, Num 5, pp 331-337, issn 0003-4509Article

LE RISQUE DE TUBERCULOSE DANS DES MILIEUX EXPOSES A UNE SURINFECTION CONSTANTE AVEC DES BACILLES TUBERCULEUX INH-SENSIBLES ET INH-RESISTANTSTELEJKO Z.1972; GRUZLICA CHOR. PLUC; POLSKA; DA. 1972; VOL. 40; NO 7; PP. 591-598; ABS. RUSSE ANGL.; BIBL. 7REF.Serial Issue

DETERMINATION INTERFEROMETRIQUE DE L'ISONIAZIDELAJPANOV A KH; LOBANOV VI.1973; FARMACIJA; S.S.S.R.; DA. 1973; VOL. 22; NO 2; PP. 48-49; ABS. ANGL.; BIBL. 3REF.Serial Issue

PERINATAL CARCINOGENICITY OF IONIAZID (INH) IN SWISS MICEMENON MM; BHIDE SV.1983; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1983; VOL. 105; NO 3; PP. 258-261; BIBL. 20 REF.Article

PLANIFICATION DE L'EXPERIENCE LORS DE L'EVALUATION DES CONDITIONS OPTIMALES DE DETERMINATION QUANTITATIVE DE L'ISONIAZIDECHEKRYSHKINA LA.1974; FARMACIJA; S.S.S.R.; DA. 1974; VOL. 23; NO 4; PP. 44-46; ABS. ANGL.Article

A favourable solubility of isoniazid, an antitubercular antibiotic drug, in alternative solventsFORTE, Andreia; MELO, Catarina I; BOGEL-LUKASIK, Rafał et al.Fluid phase equilibria. 2012, Vol 318, pp 89-95, issn 0378-3812, 7 p.Article

Action d'un antituberculeux, l'isoniazide, sur la biosynthèse des acides mycoliques = Action of an antituberculous drug, isoniazid, on mycolic acid biosynthesisQuemard, Annaik; Laneelle, Gilbert.1992, 154 p.Thesis

LA PHARMACOCINETIQUE DE L'ISONIAZIDE DANS LA RACE BLANCHE. (DONNEES FOURNIES PAR UNE ETUDE STATISTIQUE PORTANT SUR UNE DECENNIE)VIVIEN JN; THIBIER R; LEPEUPLE A et al.1973; REV. FR. MAL. RESP.; FR.; DA. 1973; VOL. 1; NO 5-6; PP. 753-772; ABS. ANGL.; BIBL. 14REF.Serial Issue

DETERMINATION VANADATOMETRIQUE DE L'ISONIAZIDE1972; FARM. ZH., U.R.S.R.; S.S.S.R.; DA. 1972; VOL. 27; NO 3; PP. 79-81; BIBL. 14 REF.Serial Issue